Arcadia Biosciences, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|
| Revenue | $4.0M | $3.2M | $5.4M | $7.0M |
| Cost of Revenue | $283.0K | $895.0K | $892.0K | $2.0M |
| Gross Profit | $3.7M | $2.3M | $4.5M | $5.0M |
| Gross Margin | 93.0% | 71.9% | 83.5% | 71.4% |
| Operating Expenses | ||||
| Research & Development | $7.4M | $8.7M | $9.0M | $10.0M |
| SG&A Expense | $10.7M | $12.3M | $11.1M | $10.1M |
| Operating Income | $-14.3M | $-18.6M | $-15.6M | $-15.2M |
| Operating Margin | -355.6% | -584.1% | -287.5% | -217.0% |
| Interest Expense | $747.0K | $1.3M | $2.7M | $1.4M |
| Pretax Income | $-15.7M | $-19.6M | $-17.9M | $-18.1M |
| Income Tax Expense | $26.0K | $25.0K | $26.0K | $263.0K |
| Net Income | $-15.7M | $-19.6M | $-18.0M | $-18.3M |
| Net Margin | -390.1% | -615.6% | -331.7% | -262.7% |
| EPS (Basic) | $-3.64 | $-4.43 | $-0.37 | $-5.36 |
| EPS (Diluted) | $-3.64 | $-4.43 | $-0.37 | $-5.36 |
| Shares Outstanding (Basic) | 4.3M | 4.4M | 88.4M | 4.1M |
| Shares Outstanding (Diluted) | 4.3M | 4.4M | 88.4M | 4.1M |
| Dividends Per Share | — | — | — | — |